Molecular determinants of acute single-cell lysis by human immunodeficiency virus type 1

Journal of Virology

Volumn 70, Issue 3, 1996, Pages 1340-1354

  Cao, Jie ^a   Park, In Woo ^a   Cooper, Andrew ^a   Sodroski, Joseph ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; DNA FRAGMENT; GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 41; TETRACYCLINE; VIRUS ENVELOPE PROTEIN;

APOPTOSIS; ARTICLE; CELL FUSION; CELL MEMBRANE; CONTROLLED STUDY; CYTOLYSIS; CYTOPATHOGENIC EFFECT; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; RADIOIMMUNOPRECIPITATION; SYNCYTIUM;

EID: 0030053308     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.3.1340-1354.1996     Document Type: Article

References (87)

1. Åsjö, B.. L. Morfeldt-Manson, L. J. Albert, G. Biberfeld, A. Karlson, K. Lidman, and E. M. Fenyo. 1986 Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infection Lancet ii:660-662
2. Barre-Sinoussi, F., J. C. Chermann, F. Rey, M. T. Nygeyre, S. Charmaret, J. Gruest, C. Dauguet, C. Axler-Blin, F. Vezinet-Brun, C. Rouzioux, W. Rozenbaum, and L. Montagnier. 1983. Isolation of a T-lymphocyte retrovirus from a patient at risk for acquired immunodeficiency syndrome (AIDS). Science 220:868-871.
3. Bergeron, L., and J. Sodroski. 1992 Dissociation of unintegrated viral DNA accumulation from single-cell lvsis induced by human immunodeficiency virus type 1 J. Virol. 66:5777-5787.
4. Bergeron, L., N. Sullivan, and J. Sodroski. 1992, Target cell-specific determinants of membrane fusion within the human immunodeficiency virus type 1 gp120 third variable region and 2p41 amino terminus. J. Virol. 66:2389-2397.
5. Bosch, V., and M. Pawlita. 1990. Mutational analysis of the human immunodeficiency virus type 1 env gene product proteolytic cleavage site. J. Virol 64:2337-2344.
6. Cao, J., B. Vasir, and J. Sodroski. 1994. Changes in the cytopathic effects of human immunodeficiency virus type 1 (HIV-1) associated with a single amino acid alteration in the ectodomain of the gp41 transmembrane glycoprotein. J. Virol. 68:4662-4668.
7. Cao, Y., L. Qin, L. Zhang, J. Safrit, and D. D. Ho. 1995. Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection N. Engl. J. Med. 332:201-208.
8. Cheng-Mayer, C., M. Quiroga, J. W. Tung, D. Dina, and J. A. Levy. 1990. Viral determinants of human immunodeficiency virus type 1 T-cell or macrophage tropism, cytopathogenicity, and CD4 antigen modulation. J. Virol 64:4390-4398.
9. Cheng-Mayer, C., D. Seto, M. Tateno, and J. A. Levy. 1988. Biologic features of HIV-1 that correlate with virulence in the host Science 240:80-82.
10. Chernomordik, L., A. N. Chanturiya, E. Suss-Toby, E. Nora, and J. Zimmerberg. 1994. An amphipathic peptide from the C-terminal region of the human immunodeficiency virus envelope glycoprotein causes pore formation in membranes. J. Virol. 68:7115-7123.
11. Choe, H.-R., and J. Sodroski. 1995 Adaptation of human immunodeficiency virus type 1 (HIV-1) to cells expressing a binding-deficient CD4 mutant (lysine 46 to aspartic acid). J. Virol. 69:2801-2810.
12. Cloyd, M., and W. Lynn. 1991. Perturbation of host cell membrane is a primary mechanism of HIV cytopathology. Virology 181:500-511.
13. Collman, R., J. W. Balliet, S. A. Gregory, H. Friedman, L. Kolson, N. Nathanson, and A. Srinivasan. 1992. An infectious molecular clone of an unusual macrophage-tropic and highly cytopathic strain of human immunodeficiency virus type 1. J. Virol. 66:7517-7521.
14. - T-lymphocyte decline and clinical progression in human immunodeficiency virus type 1-infected individuals J. Virol. 67:1772-1777.
15. Dalgleish, A. G., P. C. L. Beverley, P. R. Clapham, D. H. Crawford, M. F. Greaves, and R. A. Weiss. 1984 The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus Nature (London) 312: 763-767
16. Dayton, A. I., J. G. Sodroski, C. A. Rosen, W. C. Goh, and W. A. Haseltine. 1986. The transactivator gene of the human T-cell lymphotropic virus type III is required for replication. Cell 44:941-947.
17. Dedera, D., and L. Ratner. 1991. Demonstration of two distinct cytopathic effects with syncytium formation-defective human immunodeficiency virus type 1 mutants. J. Virol. 65:6129-6139.
18. DeRossi, A., G. Franchini, A. Aldonvini, A. DelMistro, L. Chieco-Bianchi, R. Gallo, and F. Wong-Staal. 1986. Differential response to the cytopathic effects of human T-cell lymphotropic virus type III (HTLV-III) superinfection in T4+ (helper) and T8+ (suppressor) T-cell clones transformed by HTLV-I Proc Natl Acad Sci. USA 83:4297-4301.
19. Duke, R., and J. J. Cohen. 1994. Morphological and biological assays of apoptosis, p. 3171-3179 In J. E. Coligan, A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, and W. Strober (ed.). Current protocols in immunology. John Wiley & Sons, New York.
20. Earl, P. L., R. W. Doms, and B. Moss. 1990. Oligomeric structure of the human immunodeficiency virus type 1 envelope glycoprotein Proc. Natl Acad. Sci. USA 87:648-652.
21. Earl, P. L., B. Moss, and R. W. Doms. 1991. Folding, interaction with GRP78-BiP, assembly, and transport of the human immunodeficiency virus type 1 envelope protein J. Virol 65:2047-2055.
22. Fauci, A., A. Macher, D. Longo, H. C. Lane, A. Rook, H. Masur, and E. Gelmann. 1984. Acquired immunodeficiency syndrome: epidemiologic, clinical, immunologic, and therapeutic considerations. Ann Intern. Med 100: 92-106.
23. Fauci, A. S. 1988. The human immunodeficiency virus: infectivity and mechanisms of pathogenesis. Science 239:617-622.
24. Fenyo, E. M., L. Mörfeldt-Manson, F. Chiodi, B. Lind, A. Von Gegerfelt, J. Albert, E. Olausson, and B. Åsjó. 1988. Distinct replicative and cytopathic characteristics of human immunodeficiency virus isolates J. Virol. 62:4414-4419.
25. Fernandez-Larsson, R., K. K. Srivastava, S. Lu, and H. L. Robinson. 1992. Replication of patient isolates of human immunodeficiency virus type 1 in T cells: a spectrum of rates and efficiencies of entry. Proc. Natl. Acad. Sci. USA 89:2223-2226.
26. Freed, E., D. Meyers, and R. Risser. 1990. Characterization of the fusion domain of the human immunodeficiency virus type 1 envelope glycoprotein gp41. Proc Natl Acad. Sci. USA 87:4650-4654
27. Gabuzda, D., A. Lever, E. Terwilliger, and J. Sodroski. 1992. Effects of deletions in the cytoplasmic domain on biological functions of human immunodeficiency virus type 1 envelope glycoproteins. J. Virol. 66:3306-3315
28. Gallo, R. C., S. Z. Salahuddin, M. Popovic, G. M. Shearer, M. Kaplan, B. F. Haynes, T. J. Palker, R. Redfield, J. Oleske, B. Safai, G. White, P. Foster, and P. D. Markham. 1984 Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science 224:500-503.
29. Gorczyca, W., J. Gong, and Z. Darzynkiewiez. 1993. Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynucleotidyl transferase and nick translation assays. Cancer Res. 53:1945-1951
30. Gossen, M., and H. Bujard. 1992. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad Sci. USA 89:5547-5551
31. Greber, U. F., and L. Gerace. 1995. Depletion of calcium from the lumen of endoplasmic reticulum reversibly inhibits passive diffusion and signal-mediated transport into the nucleus. J. Cell Biol. 128:5-14.
32. Helseth, E., M. Kowalski, B. Gabuzda, U. Olshevsky, W. Haseltine, and J. Sodroski. 1990. Rapid complementation assays measuring replicative potential of human immunodeficiency virus type 1 envelope glycoprotein mutants. J. Virol. 64:2416-2420.
33. Helseth, E., U. Olshevsky, D. Gabuzda, B. Ardman, W. Haseltine, and J. Sodroski. 1990. Changes in the transmembrane region of the human immunodeficiency virus type 1 gp41 envelope glycoprotein affect membrane fusion. J. Virol. 64:6314-6318
34. Ho, D., T. Moudgil, and M. Alam. 1989. Quantitation of HIV-1 in the blood of infected persons. N. Engl. J. Med. 321:1621-1625
35. Ho, D. D., A. Neumann, A. Perelson, W. Chen, J. Leonard, and M. Markowitz. 1995. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature (London) 373:123-129.
36. Hoxie, J. A., J. D. Alpers, J. L. Rackowski, K. Huebner, B. S. Haggarty, A. J. Cedarbaum, and J. C. Reed. 1986. Alterations in T4 (CD4) protein and mRNA synthesis in cells infected with HIV. Science 234:1123-1127.
37. Hussey, R., N. Richardson, M. Kowalski, N. Brown, C. Hsiu-Ching, R. Siliciano, T. Dorfman, B. Walker, J. Sodroski, and E. Reinherz. 1988. A soluble CD4 protein selectively inhibits HIV replication and syncytium formation. Nature (London) 331:78-81.
38. Jacobson, M. D., J. F. Burne, and M. C. Raff. 1994. Programmed cell death and Bcl-2 protection in the absence of a nucleus. EMBO J 13:1899-1910.
39. Kawamura, I., Y. Koga, N. Oh-hori, K. Onudera, G. Kimura, and K. Nomuto. 1989. Depletion of the surface CD4 molecule by the envelope protein of human immunodeficiency virus expressed in a human monocytoid cell line J. Virol. 63:3748-3754.
40. Klatzmann, D., E. Champagne, S. Chamaret, J. Gruest, D. Guetard, T. Hercend, J. C. Gluckman, and L. Montagnier. 1984. T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV Nature (London) 312:767-768.
41. Koga, Y., K. Nakamura, M. Sasaki, G. Kimura, and K. Nomoto. 1994. The difference in gp160 and gp120 of HIV type 1 in the induction of CD4 downregulation preceding single-cell killing. Virology 201:137-141
42. - human cell lines. J. Virol. 64:4661-4671.
43. - cells expressing gp160 of human immunodeficiency virus J. Virol. 65:5609-5612.
44. Koga, Y., M. Sasaki, H. Yoshida, H. Wigzell, G. Kimura, and K. Nomoto. 1990. Cytopathic effect determined by the amount of CD4 molecules in human cell lines expressing envelope glycoprotein of HIV J. Immunol. 144:94-102.
45. Kondo, E., T. Yoshino, I. Yamadori, Y. Matsuo, N. Kawasaki, J. Minowada, and T. Akagi. 1994. Expression of Bcl-2 protein and Fas antigen in non-Hodgkin's lymphomas Am. J. Pathol. 145:330-337.
46. Koup, R. A., J. T. Safrit, Y. Cao, C. A. Andrews, G. McLeod, W. Borkowsky, C. Farthing, and D. D. Ho. 1994. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J. Virol. 68:4640-4655.
47. Kowalski, M., L. Bergeron, T. Dorfman, W. Haseltine, and J. Sodroski. 1991. Attenuation of human immunodeficiency virus type 1 cytopathic effect by a mutation affecting the transmembrane envelope glycoprotein. J Virol. 65: 281-291
48. Kowalski, M., J. Potz, L. Basiripour, T. Dorfman, W. G. Goh, E. Terwilliger, A. Dayton, C. Rosen, W. Haseltine, and J. Sodroski. 1987 Functional regions of the human immunodeficiency virus envelope glycoproteins Science 237: 1351-1355
49. Kräusslich, H. G., C. Ochsenbauer, A. M. Traenckner, K. Mergener, M. Facke, H. R. Gelderblom, and V. Bosch. 1993. Analysis of protein expression and virus-like particle formation in mammalian cell lines stably expressing HIV-1 gag and env gene products with or without active HIV proteinase. Virology 192:605-617.
50. Laiho, K. U., and B. F. Trump. 1975. Studies on the pathogenesis of cell injury Effect of inhibitors of metabolism and membrane function on the mitochondria of Ehrlich ascites tumor cells. Lab. Invest. 32:163-182.
51. Laurent-Crawford, A. G., B. Krust, S. Muller, Y. Rivière, M.-A. Rey-Cuillé, J.-M. Béchet, L. Montagnier, and A. G. Hovanessian. 1991. The cytopathic effect of HIV is associated with apoptosis. Virology 185:829-839.
52. 51a.Laurent-Crawford, A. G., B. Krust, Y. Rivière, C. Desgranges, S. Muller, M. P. Kieny, C. Dauguet, and A. G. Hovanessian. 1993. Membrane expression of HIV envelope glycoprotein triggers apoptosis in CD4 cells. AIDS Res. Hum. Retroviruses 9:761-773.
53. Lifson, J. D., M. B. Feinberg, G. R. Reyes, L. Rabin, B. Banapour, S. Chakrabarti, B. Moss, F. Wong-Staal, K. S. Steimer, and E. B. Engleman. 1986. Induction of CD4-dependent cell fusion by the HTLV-III/LAV envelope glycoprotein. Nature (London) 323:725-728.
54. - cells expressing gp160 of human immunodeficiency virus type 1. J. Virol. 68:390-399.
55. Lynn, W. S., A. Tweedale, and M. W. Cloyd. 1988. Human immunodeficiency virus (HIV-1) cytotoxicity. perturbation of the cell membrane and depression of phospholipid synthesis. Virology 163:43-51.
56. Majno, G., and I. Joris. 1995 Apoptosis, oncosis and necrosis, an overview of cell death. Am. J. Pathol. 146:3-15.
57. McCune, J. M., L. Rabin, M. Feinberg, M. Lieberman, J. Kosek, G. Reyes, and I. Weissman. 1988. Endoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virus. Cell 53:55-67.
58. McDougal, J. S., K. Kennedy, J. Sligh, S. Cort, A. Mowie, and J. Nicholson. 1986. Binding of the HTLV-III/LAV to T4+ T cells by a complex of the 100 K viral protein and the T4 molecule Science 231:382-385.
59. McDougal, J. S., J. Nicholson, G. Cross, S. Cort, M. Kennedy, and A. Mawle. 1986. Binding of the human retrovirus HTLV-III/LAV/ARV/HIV to the CD4 (T4) molecule: conformation dependence, epitope mapping, antibody inhibition, and potential for idiotypic mimicry J. Immunol. 137:2937-2944.
60. Miller, M., M. Cloyd, J. Liebmann, C. Rinaldo, Jr., K. Islam, S. Wang, T. Mietzner, and R. Montelaro. 1993. Alteration in cell membrane permeability by the lentivirus lytic peptide (LLP-1) of HIV-1 transmembrane protein. Virology 196:89-100
61. Miller, M., T. Mietzner, M. Cloyd, W. G. Robey, and R. Montelaro. 1993. Identification of a calmodulin-binding and inhibitory peptide domain in the HIV-1 transmembrane glycoprotein. AIDS Res. Hum. Retroviruses 9:1057-1056.
62. Mulligan, M., G. Yamshchikov, G. Ritter, Jr., F. Gao, M. Jin, C. Nail, C. Spies, B. Hahn, and R. Compans. 1992. Cytoplasmic domain truncation enhances fusion activity by the exterior glycoprotein complex of human immunodeficiency virus type 2 in selected cell types. J. Virol. 66:3971-3975.
63. O'Brien, W., Y. Koyanagi, A. Namazie, J.-Q. Zho, A. Diagne, K. Idler, J. Zack, and I. S. Y. Chen. 1990 HIV-1 tropism for manonuclear phagocytes can be determined by regions of gp120 outside the CD4-binding domain. Nature (London) 348:69-73.
64. Olshevsky, U., E. Helseth, C. Furman, J. Li, W. Haseltine, and J. Sodroski. 1990. Identification of individual human immunodeficiency virus type 1 gp120 amino acids important for CD4 receptor binding J. Virol. 64:5701-5707.
65. Pantaleo, G., C. Grazinsi, J. F. Demarest, L. Butini, M. Muntroni, C. H. Fox. J. M. Orenstein, D. P. Kotler, and A, S. Fauci. 1993. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease Nature (London) 362:355-358.
66. Park, I.-W., E. Kondo, J. S. Park, L. Bergeron, and J. Sodroski. Effects of human immunodeficiency virus type 1 infection on programmed cell death in the presence or absence of Bcl-2. Submitted for publication.
67. Patterson, S., M. S. Roberts, N. R. English, S. E. Macatonia, M. N. Gompels, A. J. Pinching, and S. C. Knight. 1994. Detection of HIV DNA in peripheral blood dendritic cells of HIV-1-infected individuals Res. Virol 143:171-176
68. Popovic, M., M. Sarngadharan, E. Read, and R. Gallo. 1984. A method for detection, isolation, and continuous production of cytopathic human T-lymphotropic retroviruses of the HTLV family (HTLV-III) from patients with AIDS and pre-AIDS Science 224:497-500
69. Rogel, M., L. Wu, and M. Emerman. 1995. The human immunodeficiency virus type 1 vpr gene prevents cell proliferation during chronic infection. J. Virol. 69:882-888
70. Sodroski, J., W. C. Goh, C. A. Rosen, K. Campbell, and W. Haseltine. 1986. Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity. Nature (London) 322:470-474.
71. Sodroski, J. G., W. C. Goh, C. A. Rosen, A. Tartar, D. Portelle, A. Burny, and W. A. Haseltine. 1986 Replicative and cytopathic potential of human T-lymphotropic virus type III (HTLV-III/LAV) with sor gene deletions Science 240:1549-1553
72. Somasundaran, M., and H. L. Robinson. 1987. A major mechanism of human immunodeficiency virus-induced cell killing does not involve cell fusion. J. Virol. 61:3114-3119
73. Srinivas, S. K., R. V. Srinivas, G. M. Anantharamaiah, J. P. Segrest, and R. W. Compans. 1992. Membrane interaction of synthetic peptides corresponding to amphipathic helical segments of the human immunodeficiency virus type 1 envelope glycoprotein. J. Biol Chem. 267:7121-7127.
74. Stevenson, M., S. Haggarty, C. Lamioca, A. M. Mann, C. Meier, and W. Wasiak. 1990. Cloning and characterization of human immunodeficiency virus type 1 variants diminished in the ability to induce syncytium-independent lysis. J. Virol. 64:3792-3803.
75. + cells: mechanism for persistence in AIDS. Cell 53:483-496
76. Sullivan, N., Y. Sun, J. Li, W. Hoffman, and J. Sodroski. 1995. Replicative function and neutralization sensitivity of envelope glycoproteins from primary and T-cell line-passaged human immunodeficiency virus type 1 isolates. J. Virol. 69:4413-4422.
77. Tani, Y., H. Tian, H. C. Lane, and D. I. Cohen. 1993. Normal T cell receptor-mediated signaling in T cell lines stably expressing HIV-1 envelope glycoproteins. J. Immunol. 151:7337-7348.
78. Terai, C., R. S. Kornbluth, C. D. Pauza, D. D. Richman, and D. A. Carson. 1991. Apoptosis as a mechanism of cell death in cultured T lymphoblasts acutely infected with HIV-1 J Clin. Invest 87:1710-1715.
79. Terwilliger, E., J. G. Sodroski, C. A. Rosen, and W. A. Haseltine. 1986. Effects of mutations in the 3′-open reading frame region of human T-cell lymphotropic virus type III (HTLV-III/LAV) on replication and cytopathicity. J. Virol 60:754-760.
80. Wei, X., S. Ghosh, M. Taylor, V. Johnson, E. Emini, P. Deutsch, J. Lifson, S. Bonhoeffer, M. Nowak, B. Hahn, M. Saag, and G. Shaw. 1995. Viral dynamics in human immunodeficiency virus type 1 infection. Nature (London) 373:117-122.
81. Westervelt, P., H. E. Gendelman, and L. Ratner. 1991. Identification of a determinant within the human immunodeficiency virus surface envelope glycoprotein critical for productive infection of primary monocytes. Proc Natl. Acad. Sci. USA 88:3097-3101.
82. Wilk, T., T. Pfeiffer, and V. Bosch. 1991. Retained in vitro infectivity and cytopathogenicity of HIV-1 despite truncation of the C-terminal tail of the env gene product Virology 189:167-177.
83. Willey, R., J. Bonifacino, B. Potts, M. Martin, and R. Klausner. 1988. Biosynthesis, cleavage and degradation of the human immunodeficiency virus 1 envelope glycoprotein gp160. Proc. Natl. Acad. Sci. USA 85:9680
84. Wittekind, D. 1979. On the nature of Romanowsky dyes and the Romanowsky-Giemsa effect. Clin. Lab. Haematol. 1:247-262.
85. Wyatt, R., N. Sullivan, M. Thali, H. Repke, D. Ho, J. Robinson, M. Posner, and J. Sodroski. 1993. Characterization of human immunodeficiency virus type 1 envelope glycoproteins containing deletions of the major variable regions. J. Virol. 67:4557-4565
86. Wyllie, A. H. 1981 Cell death: a new classification separating apoptosis from necrosis, p. 9-34. In I. D. Bowen and R. A Lockshin (ed.). Cell death in biology and pathology Chapman and Hall, New York.
87. + T cells by non-syneytium-inducing macrophage-tropic human immunodeficiency virus type 1. Proc. Natl Acad Sci. USA 91:10237-10241.